Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors
Clinical trial NCT06878664 · RECRUITING
Trial details
- NCT number
- NCT06878664
- Sponsor
- Grupo Espanol de Tumores Neuroendocrinos
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-12
- Primary completion
- 2029-01-01
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.